The store will not work correctly when cookies are disabled.
1-[(4-Boronopheny)methyl]-1,4,7-triazacyclononane Ditrifluroacetic acid
ID: ALA5219542
Chembl Id: CHEMBL5219542
PubChem CID: 168298454
Max Phase: Preclinical
Molecular Formula: C15H23BF3N3O4
Molecular Weight: 263.15
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)C(F)(F)F.OB(O)c1ccc(CN2CCNCCNCC2)cc1
Standard InChI: InChI=1S/C13H22BN3O2.C2HF3O2/c18-14(19)13-3-1-12(2-4-13)11-17-9-7-15-5-6-16-8-10-17;3-2(4,5)1(6)7/h1-4,15-16,18-19H,5-11H2;(H,6,7)
Standard InChI Key: UTAKAUHJMWGZNM-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.15 | Molecular Weight (Monoisotopic): 263.1805 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
References
1. Ueda H, Suzuki M, Kuroda R, Tanaka T, Aoki S.. (2021) Design, Synthesis, and Biological Evaluation of Boron-Containing Macrocyclic Polyamines and Their Zinc(II) Complexes for Boron Neutron Capture Therapy., 64 (12.0): [PMID:34077212] [10.1021/acs.jmedchem.1c00445] |